08 November 2018 : Review article
The Role of Food-Drug-Cytochrome P450 Interactions in Breast Cancer
Claudia RelatsABCDEFG, Leila SadeghiACDE, Eveline ZbärenEF, Helena JenzerCDEDOI: 10.12659/MSRev.911528
Med Sci Rev 2018; 5:25-34
Abstract
Cytochrome P450 enzymes use a variety of molecules as substrates in enzymatic reactions, mostly catalysing oxidation of these substrates. Some of the enzymes activate carcinogenesis, including breast cancer development. The purpose of the present paper is to review and discuss the interactions between food products and substrates metabolized by enzymes of the cytochrome P450 in relation to the development of breast cancer. A review of recently published papers was undertaken. Electronic searches on nutrients, cytochrome P450, and breast cancer were performed on PUBMED, MEDLINE, EMBASE, and EBSCO in March 2018. Molecular and clinical studies indicate that diet-cytochrome P450 interactions affect the risk for developing breast cancer. However, these are early results which are limited and frequently not reproducible due to possible information bias in food frequency questionnaires. Based on a review of available literature, food products interacting with substrates metabolized by the enzymes of the cytochrome P450 and thus having a direct or indirect effect on breast cancer development were identified. Nutrition plays an important role in breast carcinogenesis. Eating foods which modify the activity of certain cytochrome P450 enzymes such as CYP1A1, CYP1A2, CYP1B1, CYP2B6, CYP3A4, CYP19A1, and CYP24A1 can contribute to prevention of breast cancer. Diet can act as an adjuvant in the treatment of this disease. Further studies are needed to elucidate the role of nutrients regularly consumed in the development of breast cancer, specifically their effect on substrates metabolized by the cytochrome P450 enzyme family and the corresponding mechanisms.
Keywords: Cytochrome P-450 Enzyme System, Food-Drug Interactions, Nutritional Sciences
Editorial
01 September 2023 : Editorial
Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2DOI: 10.12659/MSM.942244
Med Sci Monit 2023; 29:e942244
In Press
28 Sep 2023 : Clinical Research
Trends in Hospitalization Duration for Rare Diseases: A Retrospective Analysis of Sarcoidosis, Still's Dise...Med Sci Monit In Press; DOI: 10.12659/MSM.941536
27 Sep 2023 : Laboratory Research
Enhanced Proliferation and Adhesion Marker Gene Expression in Fibroblast Cells: Evaluating the Efficacy of ...Med Sci Monit In Press; DOI: 10.12659/MSM.941641
26 Sep 2023 : Clinical Research
Hypothalamic Injury and Clinical Outcomes in Patients with Post-Traumatic Hyponatremia: A Diffusion Tensor ...Med Sci Monit In Press; DOI: 10.12659/MSM.942397
26 Sep 2023 : Clinical Research
Psychometric Properties of the Polish Version of the FACIT-Sp-12: Assessing Spiritual Well-Being Among Pati...Med Sci Monit In Press; DOI: 10.12659/MSM.941769
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292